Crystal Flush launches informative e-book on toenails

Content of the article

With an estimated 35 million people in the United States affected by a toenail fungal infection, antifungal brand Crystal Flush reminds them of the potential dangers of ignoring it in a recently released eBook.

Content of the article

Dallas, TX – (Newsfile Corp. – Nov. 24, 2021) – Crystal Flush, a doctor-approved anti-fungal brand, recently launched its informational e-book titled “The 7 Dangers of Ignoring Toe Yeast Infection.” The 21-page eBook details the potential dangers that toenail fungus can cause if left untreated for a long time.

Can't see this picture?  Visit: https://orders.newsfilecorp.com/files/8033/104929_cd0349b254648a53_001.jpg

To view an improved version of this graphic, please visit:
https://orders.newsfilecorp.com/files/8033/104929_cd0349b254648a53_001full.jpg

With around 35 million people nationwide suffering from toenail fungal infection, Crystal Flush has created the informational eBook to provide everything they need to know about toenail fungus.

“We believe knowledge is power, and you need to understand what you are facing to fight this disease,” Crystal Flush wrote. “Research has shown that this fungus doesn’t stop with your fingernails. It can spread to other parts of your body and cause other problems.

Crystal Flush stressed that the entire eBook is not medical advice and encouraged readers to consult their doctor with any health-related questions.

About Crystal Flush

Crystal shard is a comprehensive treatment system targeting the external and internal causes of onychomycosis.

Crystal Flush 2-Step Treatment System, containing a clinically proven and FDA approved active ingredient, is the only toe yeast treatment available that targets both the external and internal causes of toe yeast infection.

Media contact:

https://www.crystalflush.com/

[email protected]

Company logo

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/104929

#distro


Source link

Comments are closed.